<DOC>
	<DOCNO>NCT01403545</DOCNO>
	<brief_summary>Aim present study : - To evaluate safety tolerability increase dos intravenous liposomal Curcumin healthy subject mean adverse event , vital sign safety laboratory assessment . - To investigate pharmacokinetics increase dos intravenous liposomal Curcumin healthy subject .</brief_summary>
	<brief_title>Evaluation Liposomal Curcumin Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Curcumin</mesh_term>
	<criteria>Healthy male female subject . Age 1845 year . Body mass index 1827 kg/m2 Vital sign within normal range 5 minute supine position ( SBP : ≥90 mmHg ≤140 mmHg , DBP : ≥45 mmHg ≤90 mmHg , Heart rate : ≥45 bpm ≤90 bpm ) . Normal ECG ( PRinterval ≤ 210 m , QRS duration ≤ 140 m , QTc ≤ 450 m ) . Adequate bone marrow function evidence absolute neutrophil count ≥1500 cells/µl , normal red blood cell index , hemoglobin great 11 g/dl platelet count great 150,000/µl . Normal renal function . Normal hepatic function evidence serum total bilirubin ≤1.2 mg/dl , less equal upper limit normal , alkaline phosphatase less equal upper limit normal , ASAT ALAT less equal upper limit normal . Normal coagulation profile , activate partial thromboplastin time ( aPTT ) . Normal urine analysis . Signed informed consent . Intake steroid within 2 week prior first dose study drug . Concomitant medication ( especially anticoagulants aspirin ) herbal supplement . Active infection , fever &gt; 38.5°C within three day prior first schedule day study drug dose . Current past history evidence disease ( e.g . hemolytic diathesis , anemia require substitution therapy , hemochromatosis ) could exacerbate administration liposomal curcumin . History prior malignancy within past five year except curatively treat nonmelanoma skin cancer cervical intraepithelial neoplasia . Allergy require medical treatment within last four week . Known hypersensitivity component turmeric . Participation another clinical trial within 4 week study initiation . NYHA Class 2 congestive heart failure , uncontrolled hypertension , arrhythmia . Positive HIV serology evidence active hepatitis . Unstable medical condition medical condition , include mental illness substance abuse , deem investigator likely interfere patient 's ability sign inform consent form , ability cooperate participate study , interfere interpretation result . History treat active seizure disorder CNS PNS neurological disorder . Subjects pregnant breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Liposomal Curcumin</keyword>
</DOC>